GLUT4

Last updated

SLC2A4
Insulin glucose metabolism ZP.svg
Identifiers
Aliases SLC2A4 , GLUT4, solute carrier family 2 member 4
External IDs OMIM: 138190; MGI: 95758; HomoloGene: 74381; GeneCards: SLC2A4; OMA:SLC2A4 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001042

NM_009204
NM_001359114

RefSeq (protein)

NP_001033

NP_033230
NP_001346043

Location (UCSC) Chr 17: 7.28 – 7.29 Mb Chr 11: 69.83 – 69.84 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Glucose transporter type 4 (GLUT4), also known as solute carrier family 2, facilitated glucose transporter member 4, is a protein encoded, in humans, by the SLC2A4 gene. GLUT4 is the insulin-regulated glucose transporter found primarily in adipose tissues and striated muscle (skeletal and cardiac). The first evidence for this distinct glucose transport protein was provided by David James in 1988. [5] The gene that encodes GLUT4 was cloned [6] [7] and mapped in 1989. [8]

Contents

At the cell surface, GLUT4 permits the facilitated diffusion of circulating glucose down its concentration gradient into muscle and fat cells. Once within cells, glucose is rapidly phosphorylated by glucokinase in the liver and hexokinase in other tissues to form glucose-6-phosphate, which then enters glycolysis or is polymerized into glycogen. Glucose-6-phosphate cannot diffuse back out of cells, which also serves to maintain the concentration gradient for glucose to passively enter cells. [9]

Structure

GLUT4 also contains a UBX-domain. These are ubiquitin-regulatory regions that can assist with cell signaling. PDB 2al3 EBI.jpg
GLUT4 also contains a UBX-domain. These are ubiquitin-regulatory regions that can assist with cell signaling.

Like all proteins, the unique amino acid arrangement in the primary sequence of GLUT4 is what allows it to transport glucose across the plasma membrane. In addition to the phenylalanine on the N-terminus, two Leucine residues and acidic motifs on the COOH-terminus are believed to play a key role in the kinetics of endocytosis and exocytosis. [11]

Other GLUT proteins

There are 14 total GLUT proteins separated into 3 classes based on sequence similarities. Class 1 consists of GLUT 1-4 and 14, class 2 contains GLUT 5, 7, 9 and 11, and class 3 has GLUT 6, 8, 10, 12 and 13.

Although there are some sequence differences between all GLUT proteins, they all have some basic structural components. For example, both the N and C termini in GLUT proteins are exposed to the cytoplasm of the cell, and they all have 12 transmembrane segments. [12]

Tissue distribution

Skeletal muscle

As muscles contract, they use ATP. The energy needed to make ATP comes from a variety of different pathways--such as glycolysis or oxidative phosphorylation--that ultimately use glucose as a starting material. 1008 Skeletal Muscle Contraction.jpg
As muscles contract, they use ATP. The energy needed to make ATP comes from a variety of different pathways—such as glycolysis or oxidative phosphorylation—that ultimately use glucose as a starting material.

In striated skeletal muscle cells, GLUT4 concentration in the plasma membrane can increase as a result of either exercise or muscle contraction.

During exercise, the body needs to convert glucose to ATP to be used as energy. As G-6-P concentrations decrease, hexokinase becomes less inhibited, and the glycolytic and oxidative pathways that make ATP are able to proceed. This also means that muscle cells are able to take in more glucose as its intracellular concentrations decrease. In order to increase glucose levels in the cell, GLUT4 is the primary transporter used in this facilitated diffusion. [14]

Although muscle contractions function in a similar way and also induce the translocation of GLUT4 into the plasma membrane, the two skeletal muscle processes obtain different forms of intracellular GLUT4. The GLUT4 carrier vesicles are either transferrin positive or negative, and are recruited by different stimuli. Transferrin-positive GLUT4 vesicles are utilized during muscle contraction while the transferrin-negative vesicles are activated by insulin stimulation as well as by exercise. [15] [16]

Cardiac muscle

Cardiac muscle is slightly different from skeletal muscle. At rest, they prefer to utilize fatty acids as their main energy source. As activity increases and it begins to pump faster, the cardiac muscles begin to oxidize glucose at a higher rate. [17]

 An analysis of mRNA levels of GLUT1 and GLUT4 in cardiac muscles show that GLUT1 plays a larger role in cardiac muscles than it does in skeletal muscles. [18] GLUT4, however, is still believed to be the primary transporter for glucose. [19]

Much like in other tissues, GLUT4 also responds to insulin signaling, and is transported into the plasma membrane to facilitate the diffusion of glucose into the cell.  [20] [21]

Adipose tissue

Adipose tissue, commonly known as fat, [22]  is a depository for energy in order to conserve metabolic homeostasis. As the body takes in energy in the form of glucose, some is expended, and the rest is stored as glycogen (primarily in the liver, muscle cells), or as triglyceride in adipose tissue. [23]

An imbalance in glucose intake and energy expenditure has been shown to lead to both adipose cell hypertrophy and hyperplasia, which lead to obesity. [24]  In addition, mutations in GLUT4 genes in adipocytes can also lead to increased GLUT4 expression in adipose cells, which allows for increased glucose uptake and therefore more fat stored. If GLUT4 is over-expressed, it can actually alter nutrient distribution and send excess glucose into adipose tissue, leading to increased adipose tissue mass. [24]  

Regulation

Insulin

Insulin is released from the pancreas and into the bloodstream in response to increased glucose concentration in the blood. [25] Insulin is stored in beta cells in the pancreas. When glucose in the blood binds to glucose receptors on the beta cell membrane, a signal cascade is initiated inside the cell that results in insulin stored in vesicles in these cells being released into the blood stream. [26] Increased insulin levels cause the uptake of glucose into the cells. GLUT4 is stored in the cell in transport vesicles, and is quickly incorporated into the plasma membrane of the cell when insulin binds to membrane receptors. [23]

Under conditions of low insulin, most GLUT4 is sequestered in intracellular vesicles in muscle and fat cells. As the vesicles fuse with the plasma membrane, GLUT4 transporters are inserted and become available for transporting glucose, and glucose absorption increases. [27] The genetically engineered muscle insulin receptor knock‐out (MIRKO) mouse was designed to be insensitive to glucose uptake caused by insulin, meaning that GLUT4 is absent. Mice with diabetes or fasting hyperglycemia, however, were found to be immune to the negative effects of the insensitivity. [28]

The insulin signal transduction pathway begins when insulin binds to the insulin receptor proteins. Once the transduction pathway is completed, the GLUT-4 storage vesicles becomes one with the cellular membrane. As a result, the GLUT-4 protein channels become embedded into the membrane, allowing glucose to be transported into the cell. Signal Transduction Diagram- Insulin.svg
The insulin signal transduction pathway begins when insulin binds to the insulin receptor proteins. Once the transduction pathway is completed, the GLUT-4 storage vesicles becomes one with the cellular membrane. As a result, the GLUT-4 protein channels become embedded into the membrane, allowing glucose to be transported into the cell.

The mechanism for GLUT4 is an example of a cascade effect, where binding of a ligand to a membrane receptor amplifies the signal and causes a cellular response. In this case, insulin binds to the insulin receptor in its dimeric form and activates the receptor's tyrosine-kinase domain. The receptor then recruits Insulin Receptor Substrate, or IRS-1, which binds the enzyme PI-3 kinase. PI-3 kinase converts the membrane lipid PIP2 to PIP3. PIP3 is specifically recognized by PKB (protein kinase B) and by PDK1, which can phosphorylate and activate PKB. Once phosphorylated, PKB is in its active form and phosphorylates TBC1D4, which inhibits the GTPase-activating domain associated with TBC1D4, allowing for Rab protein to change from its GDP to GTP bound state. Inhibition of the GTPase-activating domain leaves proteins next in the cascade in their active form, and stimulates GLUT4 to be expressed on the plasma membrane. [29]

RAC1 is a GTPase also activated by insulin. Rac1 stimulates reorganization of the cortical Actin cytoskeleton [30] which allows for the GLUT4 vesicles to be inserted into the plasma membrane. [31] [32] A RAC1 Knockout mouse has reduced glucose uptake in muscle tissue. [32]

Knockout mice that are heterozygous for GLUT4 develop insulin resistance in their muscles as well as diabetes. [33]

Muscle contraction

Muscle contraction stimulates muscle cells to translocate GLUT4 receptors to their surfaces. This is especially true in cardiac muscle, where continuous contraction increases the rate of GLUT4 translocation; but is observed to a lesser extent in increased skeletal muscle contraction. [34] In skeletal muscle, muscle contractions increase GLUT4 translocation severalfold, [35] and this is likely regulated by RAC1 [36] [37] and AMP-activated protein kinase. [38]

Muscle stretching

Muscle stretching also stimulates GLUT4 translocation and glucose uptake in rodent muscle via RAC1. [39]

Interactions

GLUT4 has been shown to interact with death-associated protein 6, also known as Daxx. Daxx, which is used to regulate apoptosis, has been shown to associate with GLUT4 in the cytoplasm. UBX-domains, such as the one found in GLUT4, have been shown to associate with apoptotic signaling. [10] So this interaction aids in the translocation of Daxx within the cell. [40]

In addition, recent reports demonstrated the presence of GLUT4 gene in central nervous system such as the hippocampus. Moreover, impairment in insulin-stimulated trafficking of GLUT4 in the hippocampus result in decreased metabolic activities and plasticity of hippocampal neurons, which leads to depressive like behaviour and cognitive dysfunction. [41] [42] [43]

Interactive pathway map

Click on genes, proteins and metabolites below to link to respective articles. [§ 1]

[[File:
WP534.png go to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to WikiPathwaysgo to articlego to Entrezgo to article
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
WP534.png go to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to articlego to WikiPathwaysgo to articlego to Entrezgo to article
|alt=Glycolysis and Gluconeogenesis edit]]
Glycolysis and Gluconeogenesis edit
  1. The interactive pathway map can be edited at WikiPathways: "GlycolysisGluconeogenesis_WP534".

Related Research Articles

<span class="mw-page-title-main">Insulin</span> Peptide hormone

Insulin is a peptide hormone produced by beta cells of the pancreatic islets encoded in humans by the insulin (INS) gene. It is the main anabolic hormone of the body. It regulates the metabolism of carbohydrates, fats, and protein by promoting the absorption of glucose from the blood into cells of the liver, fat, and skeletal muscles. In these tissues the absorbed glucose is converted into either glycogen, via glycogenesis, or fats (triglycerides), via lipogenesis; in the liver, glucose is converted into both. Glucose production and secretion by the liver are strongly inhibited by high concentrations of insulin in the blood. Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is thus an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules in the cells. Low insulin in the blood has the opposite effect, promoting widespread catabolism, especially of reserve body fat.

Insulin resistance (IR) is a pathological condition in which cells in insulin-sensitive tissues in the body fail to respond normally to the hormone insulin or downregulate insulin receptors in response to hyperinsulinemia.

<span class="mw-page-title-main">AMP-activated protein kinase</span> Class of enzymes

5' AMP-activated protein kinase or AMPK or 5' adenosine monophosphate-activated protein kinase is an enzyme that plays a role in cellular energy homeostasis, largely to activate glucose and fatty acid uptake and oxidation when cellular energy is low. It belongs to a highly conserved eukaryotic protein family and its orthologues are SNF1 in yeast, and SnRK1 in plants. It consists of three proteins (subunits) that together make a functional enzyme, conserved from yeast to humans. It is expressed in a number of tissues, including the liver, brain, and skeletal muscle. In response to binding AMP and ADP, the net effect of AMPK activation is stimulation of hepatic fatty acid oxidation, ketogenesis, stimulation of skeletal muscle fatty acid oxidation and glucose uptake, inhibition of cholesterol synthesis, lipogenesis, and triglyceride synthesis, inhibition of adipocyte lipogenesis, inhibition of adipocyte lipolysis, and modulation of insulin secretion by pancreatic β-cells.

<span class="mw-page-title-main">Connexon</span> Protein hexamer that forms the pore of gap junctions between cells

In biology, a connexon, also known as a connexin hemichannel, is an assembly of six proteins called connexins that form the pore for a gap junction between the cytoplasm of two adjacent cells. This channel allows for bidirectional flow of ions and signaling molecules. The connexon is the hemichannel supplied by a cell on one side of the junction; two connexons from opposing cells normally come together to form the complete intercellular gap junction channel. In some cells, the hemichannel itself is active as a conduit between the cytoplasm and the extracellular space, allowing the transference of ions and small molecules lower than 1-2 KDa. Little is known about this function of connexons besides the new evidence suggesting their key role in intracellular signaling. In still other cells connexons have been shown to occur in mitochondrial membranes and appear to play a role in heart ischaemia.

<span class="mw-page-title-main">Uniporter</span>

Uniporters, also known as solute carriers or facilitated transporters, are a type of membrane transport protein that passively transports solutes across a cell membrane. It uses facilitated diffusion for the movement of solutes down their concentration gradient from an area of high concentration to an area of low concentration. Unlike active transport, it does not require energy in the form of ATP to function. Uniporters are specialized to carry one specific ion or molecule and can be categorized as either channels or carriers. Facilitated diffusion may occur through three mechanisms: uniport, symport, or antiport. The difference between each mechanism depends on the direction of transport, in which uniport is the only transport not coupled to the transport of another solute.

<span class="mw-page-title-main">Hyperinsulinemia</span> Abnormal increase in insulin in the bloodstream relative to glucose

Hyperinsulinemia is a condition in which there are excess levels of insulin circulating in the blood relative to the level of glucose. While it is often mistaken for diabetes or hyperglycaemia, hyperinsulinemia can result from a variety of metabolic diseases and conditions, as well as non-nutritive sugars in the diet. While hyperinsulinemia is often seen in people with early stage type 2 diabetes mellitus, it is not the cause of the condition and is only one symptom of the disease. Type 1 diabetes only occurs when pancreatic beta-cell function is impaired. Hyperinsulinemia can be seen in a variety of conditions including diabetes mellitus type 2, in neonates and in drug-induced hyperinsulinemia. It can also occur in congenital hyperinsulinism, including nesidioblastosis.

<span class="mw-page-title-main">Glucose transporter</span> Family of monosaccharide transport proteins

Glucose transporters are a wide group of membrane proteins that facilitate the transport of glucose across the plasma membrane, a process known as facilitated diffusion. Because glucose is a vital source of energy for all life, these transporters are present in all phyla. The GLUT or SLC2A family are a protein family that is found in most mammalian cells. 14 GLUTS are encoded by the human genome. GLUT is a type of uniporter transporter protein.

Method of glucose uptake differs throughout tissues depending on two factors; the metabolic needs of the tissue and availability of glucose. The two ways in which glucose uptake can take place are facilitated diffusion and secondary active transport. Active transport is the movement of ions or molecules going against the concentration gradient.

<span class="mw-page-title-main">Blood sugar regulation</span> Hormones regulating blood sugar levels

Blood sugar regulation is the process by which the levels of blood sugar, the common name for glucose dissolved in blood plasma, are maintained by the body within a narrow range.

The Randle cycle, also known as the glucose fatty-acid cycle, is a metabolic process involving the cross inhibition of glucose and fatty acids for substrates. It is theorized to play a role in explaining type 2 diabetes and insulin resistance.

<span class="mw-page-title-main">RAC1</span> Protein-coding gene in humans

Rac1, also known as Ras-related C3 botulinum toxin substrate 1, is a protein found in human cells. It is encoded by the RAC1 gene. This gene can produce a variety of alternatively spliced versions of the Rac1 protein, which appear to carry out different functions.

<span class="mw-page-title-main">TBC1D4</span> Protein-coding gene in the species Homo sapiens

AS160, which was originally known as TBC1 domain family member 4 (TBC1D4), is a Rab GTPase-activating protein that in humans is encoded by the TBC1D4 gene.

<span class="mw-page-title-main">LANCL2</span> Protein-coding gene in the species Homo sapiens

LanC-like protein 2 is a protein that in humans is encoded by the LANCL2 gene. It is a protein broadly expressed in the plasma a nuclear membranes of immune, epithelial and muscle cells and a potential therapeutic target for chronic inflammatory, metabolic and immune-mediated diseases such as Crohn's disease and diabetes.

<span class="mw-page-title-main">Chemerin</span> Protein-coding gene in the species Homo sapiens

Chemerin, also known as retinoic acid receptor responder protein 2 (RARRES2), tazarotene-induced gene 2 protein (TIG2), or RAR-responsive protein TIG2 is a protein that in humans is encoded by the RARRES2 gene.

The insulin transduction pathway is a biochemical pathway by which insulin increases the uptake of glucose into fat and muscle cells and reduces the synthesis of glucose in the liver and hence is involved in maintaining glucose homeostasis. This pathway is also influenced by fed versus fasting states, stress levels, and a variety of other hormones.

<span class="mw-page-title-main">KLF15</span> Protein-coding gene in the species Homo sapiens

Krüppel-like factor 15 is a protein that in humans is encoded by the KLF15 gene in the Krüppel-like factor family. Its former designation KKLF stands for kidney-enriched Krüppel-like factor.

<span class="mw-page-title-main">Lipotoxicity</span> Metabolic disorder in which lipids accumulate in non-fat tissue

Lipotoxicity is a metabolic syndrome that results from the accumulation of lipid intermediates in non-adipose tissue, leading to cellular dysfunction and death. The tissues normally affected include the kidneys, liver, heart and skeletal muscle. Lipotoxicity is believed to have a role in heart failure, obesity, and diabetes, and is estimated to affect approximately 25% of the adult American population.

<span class="mw-page-title-main">TUG-UBL1 protein domain</span>

In molecular biology, TUG-UBL1 refers to a protein that regulates a glucose transporter called GLUT4. TUG-UBL1 is an acronym for Tether containing UBX domain for GLUT4-Ubiquitin Like 1, this is encoded for by the gene, ASPSCR1.

<span class="mw-page-title-main">RAB4B</span>

Ras-related protein Rab-4B is a protein that in humans is encoded by the RAB4B gene.

Mark Anthony Febbraio is a physiologist, academic and researcher. He is a professor and head of the Cellular and Molecular Metabolism Laboratory at the Monash Institute of Pharmaceutical Sciences (MIPS) of Monash University and a Senior Principal Research Fellow of the National Health and Medical Research Council (NHMRC).

References

  1. 1 2 3 ENSG00000288174 GRCh38: Ensembl release 89: ENSG00000181856, ENSG00000288174 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000018566 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. James DE, Brown R, Navarro J, Pilch PF (May 1988). "Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein". Nature. 333 (6169): 183–185. Bibcode:1988Natur.333..183J. doi:10.1038/333183a0. PMID   3285221. S2CID   4237493.
  6. James DE, Strube M, Mueckler M (March 1989). "Molecular cloning and characterization of an insulin-regulatable glucose transporter". Nature. 338 (6210): 83–87. Bibcode:1989Natur.338...83J. doi:10.1038/338083a0. PMID   2645527. S2CID   4285627.
  7. Birnbaum MJ (April 1989). "Identification of a novel gene encoding an insulin-responsive glucose transporter protein". Cell. 57 (2): 305–315. doi:10.1016/0092-8674(89)90968-9. PMID   2649253. S2CID   20359706.
  8. Bell GI, Murray JC, Nakamura Y, Kayano T, Eddy RL, Fan YS, et al. (August 1989). "Polymorphic human insulin-responsive glucose-transporter gene on chromosome 17p13". Diabetes. 38 (8): 1072–1075. doi:10.2337/diabetes.38.8.1072. PMID   2568955.
  9. Watson RT, Kanzaki M, Pessin JE (April 2004). "Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes". Endocrine Reviews. 25 (2): 177–204. doi: 10.1210/er.2003-0011 . PMID   15082519.
  10. 1 2 Buchberger A, Howard MJ, Proctor M, Bycroft M (March 2001). "The UBX domain: a widespread ubiquitin-like module". Journal of Molecular Biology. 307 (1): 17–24. doi:10.1006/jmbi.2000.4462. PMID   11243799.
  11. Huang S, Czech MP (April 2007). "The GLUT4 glucose transporter". Cell Metabolism. 5 (4): 237–252. doi: 10.1016/j.cmet.2007.03.006 . PMID   17403369.
  12. Mueckler M, Thorens B (2013). "The SLC2 (GLUT) family of membrane transporters". Molecular Aspects of Medicine. 34 (2–3): 121–138. doi:10.1016/j.mam.2012.07.001. PMC   4104978 . PMID   23506862.
  13. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J (2000). "16.1: Oxidation of Glucose and Fatty Acids to CO2". Molecular Cell Biology (4th ed.). New York: W. H. Freeman. ISBN   978-0-7167-3706-3.
  14. Richter EA, Hargreaves M (July 2013). "Exercise, GLUT4, and skeletal muscle glucose uptake". Physiological Reviews. 93 (3): 993–1017. doi:10.1152/physrev.00038.2012. PMID   23899560.
  15. Ploug T, van Deurs B, Ai H, Cushman SW, Ralston E (September 1998). "Analysis of GLUT4 distribution in whole skeletal muscle fibers: identification of distinct storage compartments that are recruited by insulin and muscle contractions". The Journal of Cell Biology. 142 (6): 1429–1446. doi:10.1083/jcb.142.6.1429. PMC   2141761 . PMID   9744875.
  16. Lauritzen HP (April 2013). "Insulin- and contraction-induced glucose transporter 4 traffic in muscle: insights from a novel imaging approach". Exercise and Sport Sciences Reviews. 41 (2): 77–86. doi:10.1097/JES.0b013e318275574c. PMC   3602324 . PMID   23072821.
  17. Morgan HE, Henderson MJ, Regen DM, Park CR (September 1959). "Regulation of glucose uptake in heart muscle from normal and alloxan-diabetic rats: the effects of insulin, growth hormone, cortisone, and anoxia". Annals of the New York Academy of Sciences. 82 (2): 387–402. Bibcode:1959NYASA..82..387M. doi:10.1111/j.1749-6632.1959.tb44920.x. PMID   14424107. S2CID   32458568.
  18. Laybutt DR, Thompson AL, Cooney GJ, Kraegen EW (September 1997). "Selective chronic regulation of GLUT1 and GLUT4 content by insulin, glucose, and lipid in rat cardiac muscle in vivo". The American Journal of Physiology. 273 (3 Pt 2): H1309–H1316. doi:10.1152/ajpheart.1997.273.3.H1309. PMID   9321820.
  19. Rett K, Wicklmayr M, Dietze GJ, Häring HU (January 1996). "Insulin-induced glucose transporter (GLUT1 and GLUT4) translocation in cardiac muscle tissue is mimicked by bradykinin". Diabetes. 45 Suppl 1 (Supplement 1): S66–S69. doi:10.2337/diab.45.1.S66. PMID   8529803. S2CID   7766813.
  20. Slot JW, Geuze HJ, Gigengack S, James DE, Lienhard GE (September 1991). "Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat". Proceedings of the National Academy of Sciences of the United States of America. 88 (17): 7815–7819. Bibcode:1991PNAS...88.7815S. doi: 10.1073/pnas.88.17.7815 . PMC   52394 . PMID   1881917.
  21. Luiken JJ, Glatz JF, Neumann D (August 2015). "Cardiac contraction-induced GLUT4 translocation requires dual signaling input". Trends in Endocrinology and Metabolism. 26 (8): 404–410. doi:10.1016/j.tem.2015.06.002. PMID   26138758. S2CID   171571.
  22. "Adipose tissue". ScienceDaily. Retrieved 2017-05-24.
  23. 1 2 Favaretto F, Milan G, Collin GB, Marshall JD, Stasi F, Maffei P, et al. (2014-10-09). "GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance". PLOS ONE. 9 (10): e109540. Bibcode:2014PLoSO...9j9540F. doi: 10.1371/journal.pone.0109540 . PMC   4192353 . PMID   25299671.
  24. 1 2 Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB (October 1993). "Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue". The Journal of Biological Chemistry. 268 (30): 22243–22246. doi: 10.1016/S0021-9258(18)41516-5 . PMID   8226728.
  25. "Insulin Synthesis and Secretion". www.vivo.colostate.edu. Retrieved 2017-05-24.
  26. Fu Z, Gilbert ER, Liu D (January 2013). "Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes". Current Diabetes Reviews. 9 (1): 25–53. doi:10.2174/1573399811309010025. PMC   3934755 . PMID   22974359.
  27. Cushman SW, Wardzala LJ (May 1980). "Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane". The Journal of Biological Chemistry. 255 (10): 4758–4762. doi: 10.1016/S0021-9258(19)85561-8 . PMID   6989818.
  28. Sonksen P, Sonksen J (July 2000). "Insulin: understanding its action in health and disease". British Journal of Anaesthesia. 85 (1): 69–79. doi: 10.1093/bja/85.1.69 . PMID   10927996.
  29. Leto D, Saltiel AR (May 2012). "Regulation of glucose transport by insulin: traffic control of GLUT4". Nature Reviews. Molecular Cell Biology. 13 (6): 383–396. doi:10.1038/nrm3351. PMID   22617471. S2CID   39756994.
  30. JeBailey L, Wanono O, Niu W, Roessler J, Rudich A, Klip A (February 2007). "Ceramide- and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells". Diabetes. 56 (2): 394–403. doi: 10.2337/db06-0823 . PMID   17259384.
  31. Sylow L, Kleinert M, Pehmøller C, Prats C, Chiu TT, Klip A, et al. (February 2014). "Akt and Rac1 signaling are jointly required for insulin-stimulated glucose uptake in skeletal muscle and downregulated in insulin resistance". Cellular Signalling. 26 (2): 323–331. doi:10.1016/j.cellsig.2013.11.007. PMID   24216610.
  32. 1 2 Sylow L, Jensen TE, Kleinert M, Højlund K, Kiens B, Wojtaszewski J, et al. (June 2013). "Rac1 signaling is required for insulin-stimulated glucose uptake and is dysregulated in insulin-resistant murine and human skeletal muscle". Diabetes. 62 (6): 1865–1875. doi:10.2337/db12-1148. PMC   3661612 . PMID   23423567.
  33. Stenbit AE, Tsao TS, Li J, Burcelin R, Geenen DL, Factor SM, et al. (October 1997). "GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes". Nature Medicine. 3 (10): 1096–1101. doi:10.1038/nm1097-1096. PMID   9334720. S2CID   8643507.
  34. Lund S, Holman GD, Schmitz O, Pedersen O (June 1995). "Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin". Proceedings of the National Academy of Sciences of the United States of America. 92 (13): 5817–5821. Bibcode:1995PNAS...92.5817L. doi: 10.1073/pnas.92.13.5817 . PMC   41592 . PMID   7597034.
  35. Jensen TE, Sylow L, Rose AJ, Madsen AB, Angin Y, Maarbjerg SJ, et al. (October 2014). "Contraction-stimulated glucose transport in muscle is controlled by AMPK and mechanical stress but not sarcoplasmatic reticulum Ca(2+) release". Molecular Metabolism. 3 (7): 742–753. doi:10.1016/j.molmet.2014.07.005. PMC   4209358 . PMID   25353002.
  36. Sylow L, Møller LL, Kleinert M, Richter EA, Jensen TE (December 2014). "Rac1--a novel regulator of contraction-stimulated glucose uptake in skeletal muscle". Experimental Physiology. 99 (12): 1574–1580. doi: 10.1113/expphysiol.2014.079194 . PMID   25239922.
  37. Sylow L, Jensen TE, Kleinert M, Mouatt JR, Maarbjerg SJ, Jeppesen J, et al. (April 2013). "Rac1 is a novel regulator of contraction-stimulated glucose uptake in skeletal muscle". Diabetes. 62 (4): 1139–1151. doi:10.2337/db12-0491. PMC   3609592 . PMID   23274900.
  38. Mu J, Brozinick JT, Valladares O, Bucan M, Birnbaum MJ (May 2001). "A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle". Molecular Cell. 7 (5): 1085–1094. doi: 10.1016/s1097-2765(01)00251-9 . PMID   11389854.
  39. Sylow L, Møller LL, Kleinert M, Richter EA, Jensen TE (February 2015). "Stretch-stimulated glucose transport in skeletal muscle is regulated by Rac1". The Journal of Physiology. 593 (3): 645–656. doi:10.1113/jphysiol.2014.284281. PMC   4324711 . PMID   25416624.
  40. Lalioti VS, Vergarajauregui S, Pulido D, Sandoval IV (May 2002). "The insulin-sensitive glucose transporter, GLUT4, interacts physically with Daxx. Two proteins with capacity to bind Ubc9 and conjugated to SUMO1". The Journal of Biological Chemistry. 277 (22): 19783–19791. doi: 10.1074/jbc.M110294200 . PMID   11842083.
  41. Patel SS, Udayabanu M (March 2014). "Urtica dioica extract attenuates depressive like behavior and associative memory dysfunction in dexamethasone induced diabetic mice". Metabolic Brain Disease. 29 (1): 121–130. doi:10.1007/s11011-014-9480-0. PMID   24435938. S2CID   10955351.
  42. Piroli GG, Grillo CA, Reznikov LR, Adams S, McEwen BS, Charron MJ, et al. (2007). "Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus". Neuroendocrinology. 85 (2): 71–80. doi:10.1159/000101694. PMID   17426391. S2CID   38081413.
  43. Huang CC, Lee CC, Hsu KS (2010). "The role of insulin receptor signaling in synaptic plasticity and cognitive function". Chang Gung Medical Journal. 33 (2): 115–125. PMID   20438663.